These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35360845)

  • 21. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer.
    Zhang M; Liu Y; Liu Y; Hou S; Li H; Ma Y; Wang C; Chen X
    Front Genet; 2022; 13():978493. PubMed ID: 36092866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
    Luo Y; Sun X; Xiong J
    Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum: Identification of mRNAs and lncRNAs Involved in the Regulation of Follicle Development in Goat.
    Zhao Z; Zou X; Lu T; Deng M; Li Y; Guo Y; Sun B; Liu G; Liu D
    Front Genet; 2020; 11():647155. PubMed ID: 33603769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator.
    Li X; Yuan Y; Pal M; Jiang X
    Front Oncol; 2022; 12():972329. PubMed ID: 35957918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma.
    Liu DL; Wu MY; Zhang TN; Wang CG
    Front Mol Biosci; 2022; 9():807502. PubMed ID: 35155577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
    Chigaev M; Yu H; Samuels DC; Sheng Q; Oyebamiji O; Ness S; Yue W; Zhao YY; Guo Y
    Front Genet; 2020; 11():162. PubMed ID: 32161619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 31. Comprehensive analysis of m
    Liu T; Li H; Du G; Ma J; Shen J; Zhao H; Luo F; Li H
    Gene; 2022 May; 821():146250. PubMed ID: 35151825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer.
    Meng Q; Lu YX; Ruan DY; Yu K; Chen YX; Xiao M; Wang Y; Liu ZX; Xu RH; Ju HQ; Qiu MZ
    Mol Ther Nucleic Acids; 2021 Jun; 24():695-710. PubMed ID: 33996253
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Liu L; Wang C; Li S; Qu Y; Xue P; Ma Z; Zhang X; Bai H; Wang J
    Front Immunol; 2021; 12():677169. PubMed ID: 34354701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma.
    Nguyen TT; Lee HS; Burt BM; Wu J; Zhang J; Amos CI; Cheng C
    Genome Med; 2022 Jan; 14(1):5. PubMed ID: 35016696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma.
    Li X; Qiu N; Li Q
    Front Genet; 2022; 13():1057431. PubMed ID: 36338965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
    Li X; Qiu N; Li Q
    Front Genet; 2021; 12():838600. PubMed ID: 35145547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer.
    Lai D; Tan L; Zuo X; Liu D; Jiao D; Wan G; Lu C; Shen D; Gu X
    Front Genet; 2022; 13():973325. PubMed ID: 35937982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma.
    Kawana S; Saito R; Miki Y; Kimura Y; Abe J; Sato I; Endo M; Sugawara S; Sasano H
    Cancer Med; 2021 Jan; 10(2):718-727. PubMed ID: 33305905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum: Corrigendum: Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma.
    Frontiers Production Office
    Front Genet; 2022; 13():1089027. PubMed ID: 36468016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.